» Factor V Deficient Plasma Immunodepleted

HEMOSTASIS COAGULATION ROUTINE LYOPHILIZED IMMUNODEPLETED DEFICIENT PLASMAS EXTRINSIC PATHWAY FACTOR V

Factor V Deficient Plasma Immunodepleted

Lyophilized plasmas

Plasma deficient for Factor V assay.

Factor V Deficient Plasma is lyophilized and immuno-depleted human plasma with coagulant activity < 3% for FV.

Access on the manufacturer's website TECHNOCLONE

Reference	4-5134004
Presentation	Vial
Format	5 x 1.0 mL
Number of assays	100
Quote

Price list, safety data sheets and notices are accessible to our registered customers.

Reference	Presentation	Format	Number of assays	Quote	Product sheet
4-5134004	Vial	5 x 1.0 mL	100

Price list, safety data sheets and notices are accessible to our registered customers.

Factor V (FV) is a protein mainly synthesized by the liver. It is the enzymatic cofactor of FX and is activated in FVa by thrombin and / or FXa.
It forms with FXa a complex which, in the presence of phospholipids and calcium, activates prothrombin to thrombin. The FVa is neutralized by the PCa.

- Deficient plasma of human origin, stabilized and lyophilized with an activity < 3% of the corresponding coagulation factor.
- All other coagulation factors have normal values.
- Deficient plasma obtained by immunoadsorption.
- The FV-deficient plasma is used for the determination of FV by the one-step method using a specific thromboplastin. It can be used for the determination of resistance to PCa.

- Deficient plasma can be aliquoted and frozen for 1 month at -20 °C after reconstitution.

- 5 vials x 1 mL lyophilized plasma

Coagulation Control A
Coagulation Control N
Coagulation Reference

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION ROUTINE LYOPHILIZED IMMUNODEPLETED DEFICIENT PLASMAS EXTRINSIC PATHWAY FACTOR V